Whereas there is no evidence of ADAM8 gene amplification in many of these cancers, several pathways commonly dysregulated in aggressive malignancies were found to induce ADAM8 mRNA levels, e.g., RelB NF-κB and EGFR (Sriraman et al, 2008). Here, NFKB1 is linked to cancer.